ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 35 filers reported holding ESSA PHARMA INC in Q3 2023. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,675,608 | +4.4% | 1,855,400 | -24.6% | 0.10% | +11.0% |
| Q3 2022 | $4,477,000 | -42.2% | 2,460,000 | 0.0% | 0.09% | -48.9% |
| Q2 2022 | $7,749,000 | -49.0% | 2,460,000 | 0.0% | 0.18% | -43.8% |
| Q1 2022 | $15,203,000 | -56.5% | 2,460,000 | 0.0% | 0.32% | -57.2% |
| Q4 2021 | $34,932,000 | +78.2% | 2,460,000 | +0.4% | 0.74% | +70.7% |
| Q3 2021 | $19,600,000 | -75.1% | 2,450,000 | -10.9% | 0.43% | -79.6% |
| Q2 2021 | $78,568,000 | -4.8% | 2,750,000 | -3.2% | 2.12% | -6.8% |
| Q1 2021 | $82,502,000 | +170.3% | 2,840,000 | +11.0% | 2.28% | +130.0% |
| Q4 2020 | $30,517,000 | +111.8% | 2,558,000 | +22.5% | 0.99% | +48.4% |
| Q3 2020 | $14,406,000 | – | 2,087,800 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 2,070,052 | $60,135,000 | 10.84% |
| Burrage Capital Management LLC | 237,442 | $6,898,000 | 5.59% |
| Asymmetry Capital Management, L.P. | 284,459 | $8,264,000 | 4.28% |
| BVF INC/IL | 2,908,326 | $84,487,000 | 3.17% |
| Stenahm Asset Managment Ltd | 147,113 | $4,274,000 | 3.01% |
| ACUTA CAPITAL PARTNERS, LLC | 287,000 | $8,337,000 | 3.01% |
| Avidity Partners Management LP | 2,840,000 | $82,502,000 | 2.28% |
| Vivo Capital, LLC | 2,068,907 | $60,102,000 | 2.11% |
| COMMODORE CAPITAL LP | 176,821 | $5,137,000 | 2.05% |
| Ally Bridge Group (NY) LLC | 363,185 | $10,551,000 | 2.02% |